Shine Technologies, LLC, a next-generation fusion technology company, opened the largest facility in North America dedicated to the production of non-carrier-added lutetium-177, a medical isotope used in targeted cancer therapies. The new facility, which will operate at Shine’s headquarters in Janesville, WI, is expected to have an initial production capacity of 100,000 doses of Lu-177 per year, with the ability to further expand production capacity to 200,000 doses per year in the future. ...